|
99
|
350
|
5eknA |
Crystal structure of mapk13 complex with inhibitor |
|
111
|
348
|
5buiA |
Erk2 complexed with 2-pyridiyl tetrahydroazaindazole |
|
115
|
350
|
5bvdA |
Tetrahydropyrrolo-diazepenones as inhibitors of erk2 kinase |
|
109
|
350
|
5bujA |
Erk2 complexed with a n-h tetrahydroazaindazole |
|
107
|
350
|
5bvfA |
Tetrahydropyrrolo-diazepenones as inhibitors of erk2 kinase |
|
107
|
346
|
5byyA |
Erk5 in complex with small molecule |
|
109
|
348
|
5bueA |
Erk2 complexed with n-benzylpyridone tetrahydroazaindazole |
|
111
|
345
|
4zzoA |
Human erk2 in complex with an irreversible inhibitor |
|
114
|
345
|
4zznA |
Human erk2 in complex with an inhibitor |
|
100
|
355
|
4yr8A |
Crystal structure of jnk in complex with a regulator protein |
|
117
|
348
|
4f9wA |
Human p38alpha mapk in complex with a novel and selective small molecule inhibitor |
|
117
|
350
|
4fa2A |
Human p38 alpha mitogen-activated kinase in complex with sb239063 |
|
109
|
350
|
4erkA |
The complex structure of the map kinase erk2/olomoucine |
|
123
|
348
|
4qteA |
Structure of erk2 in complex with vtx-11e, 4-{2-[(2-chloro-4-fluorophenyl)amino]-5-methylpyrimidin-4-yl}-n-[(1s)-1-(3-chlorophenyl)-2-hydroxyethyl]-1h-pyrrole-2-carboxamide |
|
107
|
349
|
4ewqA |
Human p38 alpha mapk in complex with a pyridazine based inhibitor |
|
112
|
349
|
4f9yA |
Human p38 alpha mapk in complex with a novel and selective small molecule inhibitor |
|
100
|
350
|
4eyjA |
Mapk13 complex with inhibitor |
|
103
|
350
|
4eymA |
Mapk13 complex with inhibitor |
|
105
|
348
|
4e8aA |
The crystal structure of p38a map kinase in complex with pia24 |
|
106
|
348
|
4e5bA |
Structure of p38a map kinase without bog |
|
108
|
351
|
4eh7A |
Human p38 map kinase in complex with np-f6 and rl87 |
|
109
|
351
|
4eh3A |
Human p38 map kinase in complex with np-f2 and rl87 |
|
109
|
351
|
4eh2A |
Human p38 map kinase in complex with np-f1 and rl87 |
|
106
|
351
|
4eh4A |
Human p38 map kinase in complex with np-f3 and rl87 |
|
105
|
351
|
4eh8A |
Human p38 map kinase in complex with np-f7 and rl87 |
|
103
|
351
|
4eh5A |
Human p38 map kinase in complex with np-f4 and rl87 |
|
95
|
354
|
4e73A |
Crystal structure of jnk1beta-jip in complex with an azaquinolone inhbitor |
|
104
|
351
|
4eh6A |
Human p38 map kinase in complex with np-f5 and rl87 |
|
109
|
348
|
4e6aA |
P38a-pia23 complex |
|
104
|
350
|
4eh9A |
Human p38 map kinase in complex with np-f11 and rl87 |
|
111
|
348
|
4ehvA |
Human p38 map kinase in complex with np-f10 and rl87 |
|
104
|
348
|
4e6cA |
P38a-perifosine complex |
|
105
|
351
|
4e5aX |
The w197a mutant of p38a map kinase |
|
104
|
351
|
4dljA |
Human p38 map kinase in complex with rl163 |
|
110
|
350
|
4dliA |
Human p38 map kinase in complex with rl87 |
|
100
|
347
|
4b99A |
Crystal structure of mapk7 (erk5) with inhibitor |
|
110
|
357
|
4awiA |
Human jnk1alpha kinase with 4-phenyl-7-azaindole ikk2 inhibitor. |
|
113
|
359
|
3zuvA |
Crystal structure of a designed selected ankyrin repeat protein in complex with the phosphorylated map kinase erk2 |
|
107
|
358
|
3zyaA |
Human p38 map kinase in complex with 2-amino-phenylamino- dibenzosuberone |
|
111
|
349
|
3zshA |
X-ray structure of p38alpha bound to scio-469 |
|
106
|
347
|
3zsiA |
X-ray structure of p38alpha bound to vx-745 |
|
112
|
352
|
3zs5A |
Structural basis for kinase selectivity of three clinical p38alpha inhibitors |
|
104
|
349
|
4a9yA |
P38alpha map kinase bound to cmpd 8 |
|
102
|
344
|
3zu7A |
Crystal structure of a designed selected ankyrin repeat protein in complex with the map kinase erk2 |
|
110
|
348
|
4aa5A |
P38alpha map kinase bound to cmpd 33 |
|
116
|
349
|
3zsgA |
X-ray structure of p38alpha bound to tak-715 |
|
109
|
347
|
4aa0A |
P38alpha map kinase bound to cmpd 2 |
|
105
|
355
|
4aacA |
P38alpha map kinase bound to cmpd 29 |
|
114
|
351
|
4aa4A |
P38alpha map kinase bound to cmpd 22 |
|
110
|
358
|
3vuiA |
Crystal structure of a cysteine-deficient mutant m2 in map kinase jnk1 |
